A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
- PMID: 19591938
- DOI: 10.1016/j.nbd.2009.06.009
A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease
Abstract
Based on the pathophysiological role of adenosine A(2A) receptors in HD, we have evaluated the association of the 1976C/T single-nucleotide polymorphism in the ADORA2A gene (rs5751876) with residual age at onset (AAO) in HD. The study population consisted of 791 unrelated patients belonging to the Huntington French Speaking Network. The variability in AAO attributable to the CAG repeats number was calculated by linear regression using the log (AAO) as the dependent variable, and the respective rs5751876 genotypes as independent variables. We show that the rs5751876 variant significantly influences the variability in AAO. The R(2) statistic rose slightly but significantly (p=0.019) when rs5751876 T/T genotype was added to the regression model. Patients harbouring T/T genotype have an earlier AAO of 3.8 years as compared to C/C genotype (p=0.02). Our data thus strengthens the pathophysiological role of A(2A) receptors in Huntington's disease.
Similar articles
-
Age at onset in Huntington's disease: replication study on the association of HAP1.Parkinsonism Relat Disord. 2012 Nov;18(9):1027-8. doi: 10.1016/j.parkreldis.2012.05.020. Epub 2012 Jun 12. Parkinsonism Relat Disord. 2012. PMID: 22698993
-
Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3498-503. doi: 10.1073/pnas.0308679101. Epub 2004 Mar 1. Proc Natl Acad Sci U S A. 2004. PMID: 14993615 Free PMC article.
-
The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease.Nat Genet. 1993 Aug;4(4):398-403. doi: 10.1038/ng0893-398. Nat Genet. 1993. PMID: 8401589
-
Huntington's disease: the current state of research with peripheral tissues.Exp Neurol. 2009 Oct;219(2):385-97. doi: 10.1016/j.expneurol.2009.05.012. Epub 2009 May 19. Exp Neurol. 2009. PMID: 19460373 Review.
-
[Huntington's disease].Tidsskr Nor Laegeforen. 2008 Oct 9;128(19):2214-7. Tidsskr Nor Laegeforen. 2008. PMID: 18846148 Review. Norwegian.
Cited by
-
TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease.Biochem Biophys Res Commun. 2012 Aug 3;424(3):404-8. doi: 10.1016/j.bbrc.2012.06.120. Epub 2012 Jul 3. Biochem Biophys Res Commun. 2012. PMID: 22771793 Free PMC article.
-
Modern Genome Editing Technologies in Huntington's Disease Research.J Huntingtons Dis. 2017;6(1):19-31. doi: 10.3233/JHD-160222. J Huntingtons Dis. 2017. PMID: 28128770 Free PMC article. Review.
-
Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.J Genet. 2018 Jul;97(3):625-648. J Genet. 2018. PMID: 30027900 Review.
-
Metabolic Aspects of Adenosine Functions in the Brain.Front Pharmacol. 2021 May 14;12:672182. doi: 10.3389/fphar.2021.672182. eCollection 2021. Front Pharmacol. 2021. PMID: 34054547 Free PMC article. Review.
-
Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.PLoS One. 2015 Jul 6;10(7):e0131573. doi: 10.1371/journal.pone.0131573. eCollection 2015. PLoS One. 2015. PMID: 26148071 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical